nitroglycerin has been researched along with ranolazine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 10 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dasgupta, P; Hughes, LO; Jain, D; Lahiri, A; Raftery, EB | 1 |
| Bueno, O; Zavecz, JH | 1 |
| Chierchia, SL; Fragasso, G | 1 |
| Chaitman, BR; Chumakova, G; Kuch, J; Parker, JO; Pepine, CJ; Skettino, SL; Skopal, J; Wang, W; Wolff, AA | 1 |
| Chaitman, BR; Crager, M; Timmis, AD | 1 |
| Blokhin, A; Gratsiansky, NA; Huang, IZ; Meng, L; Stone, PH | 1 |
| Kloner, RA; Reffelmann, T | 1 |
| Belardinelli, L; Nieminen, T; Pegler, JR; Tavares, CA; Verrier, RL | 1 |
| Franck, AJ; Frohnapple, DJ; Gillette, MA; Reeder, DN | 1 |
| Arnold, SV; Belardinelli, L; Ben-Yehuda, O; Chaitman, BR; Jones, PG; Katz, A; Kosiborod, M; Li, Y; McGuire, DK; Olmsted, A; Spertus, JA; Yue, P | 1 |
| Arnold, SV; Ben-Yehuda, O; Kosiborod, M; Li, Y; McGuire, DK; Spertus, JA; Yue, P | 1 |
| Dixit, D; Kimborowicz, K | 1 |
| Rehberger-Likozar, A; Šebeštjen, M | 1 |
| Ghushchyan, V; Hartsfield, CL; Koch, BR; Nair, KV; Page, RL; Read, RA | 1 |
| Hartsfield, C; Kazi, DS; Koch, B; Meyer, N; Nguyen, L; Tran, O | 1 |
5 review(s) available for nitroglycerin and ranolazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacologic therapy of angina pectoris.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Aspirin; Calcium Channel Blockers; Drug Therapy, Combination; Enoximone; Heparin; Humans; Isosorbide Dinitrate; Niacinamide; Nicorandil; Nitroglycerin; Piperazines; Ranolazine; Vasodilator Agents | 1995 |
Metabolic management of ischaemic heart disease.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Carnitine; Energy Metabolism; Humans; Myocardium; Nitroglycerin; Piperazines; Ranolazine; Trimetazidine | 1993 |
Ranolazine: an anti-anginal drug with further therapeutic potential.
Topics: Acetanilides; Angina Pectoris; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Approval; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Nitroglycerin; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Survival Rate; Treatment Outcome; United States | 2010 |
Pharmacologic management of chronic stable angina.
Topics: Adrenergic beta-Antagonists; Angina, Stable; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Humans; Isosorbide Dinitrate; Ivabradine; Nicorandil; Nitroglycerin; Ranolazine; Sodium Channel Blockers; Vasodilator Agents | 2015 |
6 trial(s) available for nitroglycerin and ranolazine
| Article | Year |
|---|---|
Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Topics: Acetanilides; Adrenergic beta-Antagonists; Aged; Amlodipine; Angina Pectoris; Atenolol; Calcium Channel Blockers; Cardiovascular Agents; Chronic Disease; Diltiazem; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Nitroglycerin; Physical Exertion; Piperazines; Ranolazine; Survival Analysis | 2004 |
Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes.
Topics: Acetanilides; Aged; Angina Pectoris; Chronic Disease; Diabetic Angiopathies; Double-Blind Method; Enzyme Inhibitors; Exercise Tolerance; Female; Glycated Hemoglobin; Humans; Male; Nitroglycerin; Piperazines; Ranolazine; Treatment Outcome; Vasodilator Agents | 2006 |
Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
Topics: Acetanilides; Aged; Amlodipine; Angina Pectoris; Chronic Disease; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Incidence; Male; Middle Aged; Nitroglycerin; Piperazines; Ranolazine; Treatment Outcome; Vasodilator Agents | 2006 |
Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina).
Topics: Acetanilides; Aged; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Enzyme Inhibitors; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Nitroglycerin; Piperazines; Ranolazine; Sodium Channel Blockers; Treatment Outcome; Vasodilator Agents | 2013 |
Effects of ranolazine on quality of life among patients with diabetes mellitus and stable angina.
Topics: Acetanilides; Aged; Angina, Stable; Diabetes Mellitus, Type 2; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Nitroglycerin; Patient Satisfaction; Piperazines; Quality of Life; Ranolazine; Treatment Outcome; Vasodilator Agents | 2014 |
Influence of trimetazidine and ranolazine on endothelial function in patients with ischemic heart disease.
Topics: Adult; Aged; Blood Flow Velocity; Brachial Artery; Double-Blind Method; Endothelium, Vascular; Humans; Male; Middle Aged; Myocardial Ischemia; Nitroglycerin; Ranolazine; Sodium Channel Blockers; Treatment Outcome; Trimetazidine; Ultrasonography, Doppler; Vasodilation; Vasodilator Agents | 2015 |
5 other study(ies) available for nitroglycerin and ranolazine
| Article | Year |
|---|---|
Ranolazine (RS-43285): a preliminary study of a new anti-anginal agent with selective effect on ischaemic myocardium.
Topics: Acetanilides; Angina Pectoris; Animals; Blood Pressure; Coronary Disease; Electrocardiography; Exercise Test; Heart Rate; Nitroglycerin; Piperazines; Ranolazine; Single-Blind Method | 1990 |
Ranolazine injection into coronary or femoral arteries exerts marked, transient regional vasodilation without systemic hypotension in an intact porcine model.
Topics: Acetanilides; Adrenergic alpha-1 Receptor Agonists; Angina Pectoris; Animals; Blood Pressure; Coronary Vessels; Endothelium, Vascular; Femoral Artery; Humans; Models, Animal; Nitroglycerin; Piperazines; Prazosin; Ranolazine; Receptors, Adrenergic, alpha-1; Regional Blood Flow; Swine; Vascular Resistance; Vasodilation | 2011 |
Clinical experience with ranolazine in a veteran population with chronic stable angina.
Topics: Acetanilides; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angina, Stable; Calcium Channel Blockers; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitroglycerin; Piperazines; Ranolazine; Retrospective Studies; Surveys and Questionnaires; Treatment Outcome; Vasodilator Agents; Veterans | 2012 |
Comparative Effectiveness of Ranolazine Versus Traditional Therapies in Chronic Stable Angina Pectoris and Concomitant Diabetes Mellitus and Impact on Health Care Resource Utilization and Cardiac Interventions.
Topics: Adrenergic beta-Antagonists; Aged; Angina, Stable; Calcium Channel Blockers; Cardiovascular Agents; Chronic Disease; Comparative Effectiveness Research; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Health Resources; Humans; Male; Nitroglycerin; Ranolazine; Retrospective Studies; Risk Factors; Treatment Outcome; United States; Vasodilator Agents | 2015 |
Revascularization Rates and Associated Costs in Patients With Stable Ischemic Heart Disease Initiating Ranolazine Versus Traditional Antianginals as Add-on Therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Delayed-Action Preparations; Female; Follow-Up Studies; Health Care Costs; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Nitroglycerin; Ranolazine; Retrospective Studies; Sodium Channel Blockers; Treatment Outcome; United States; Vasodilator Agents; Young Adult | 2019 |